Viridian Therapeutics, Inc.

VRDN ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
4 Aug 20, 2026 4
SCHEDULE 13G Aug 20, 2026
144 Aug 19, 2026
4 Aug 18, 2026 4
SCHEDULE 13G/A Aug 14, 2026
SCHEDULE 13G/A Aug 14, 2026
SCHEDULE 13G Aug 14, 2026
SCHEDULE 13G/A Aug 14, 2026
SCHEDULE 13G Aug 7, 2026
10-Q Aug 6, 2026 10-Q
8-K Aug 6, 2026 8-K
4 Jul 2, 2026 4
4 Jul 2, 2026 4
4 Jul 2, 2026 4
4 Jul 2, 2026 4
4 Jul 2, 2026 4
4 Jul 2, 2026 4
8-K Jun 29, 2026 8-K
SCHEDULE 13G Jun 26, 2026
8-K Jun 3, 2026 8-K
8-K May 28, 2026 8-K
8-K May 26, 2026 8-K
SCHEDULE 13G May 15, 2026
4 May 13, 2026 OWNERSHIP DOCUMENT
SCHEDULE 13D/A May 13, 2026
← Newer Page 1 of 33 · 815 filings Older →